Wednesday, December 17, 2025 | 12:25 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Orchid Chemicals & Pharmaceuticals receives Establishment Inspection Report (EIR) from USFDA

Image

Capital Market

For its formulation manufacturing facility in Sriperumbudur

Orchid Chemicals & Pharmaceuticals announced that Orchid received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection closure for the formulation manufacturing facility located at Irungattukottai, Sriperumbudur, Kancheepuram District, India. The facility was inspected by USFDA in the month of May 2015.

Powered by Capital Market - Live News

 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 31 2015 | 5:45 PM IST

Explore News